Evidence map›Paper›PMID 42046598›Full record

ArticleCureus2026

New-Onset Status Epilepticus and Severe Behavioural Dysfunction in Anti-Gamma-Aminobutyric Acid B Receptor Encephalitis.

Min Huang Chua, Yuen Kang Chia

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Immune dysregulation and epileptogenesis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Min Huang ChuaInternal Medicine, Hospital Queen Elizabeth, Kota Kinabalu, MYS.
Yuen Kang ChiaNeurology, Hospital Queen Elizabeth, Kota Kinabalu, MYS.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The autoimmune encephalitides are an increasingly recognised group of neurological disorders. Among them, anti-gamma-aminobutyric acid B receptor (anti-GABA(B)R) encephalitis is a severe, frequently paraneoplastic autoimmune syndrome characterised by early, refractory seizures and prominent limbic dysfunction. Because initial neuroimaging and cerebrospinal fluid studies may be unremarkable, early cognitive and psychiatric manifestations are frequently misattributed to primary psychiatric disorders or adverse effects of anti-seizure medications. Here, we report the first case of a patient with anti-GABA(B)R encephalitis who first presented with the common symptom of a seizure in the state of Sabah, Malaysia.

Indexed as

autoimmune encephalitisbehaviouralcyclophosphamidegaba(b)rstatus epilepticus

Identifiers

PMID42046598
PMCPMC13110893

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.